McKesson Canada, a company focused on providing the healthcare industry with medicines, supplies and developing information technologies, has appointed Alain Champagne as its new president. He replaces Nick Loporcaro in the role, after Loporcaro was appointed president of McKesson Specialty Health.
Champagne has worked at the company since 2010, and was most recently its Senior Vice President of Pharmaceutical Distribution and Operations.
“Alain brings a deep knowledge of McKesson Canada’s business and customers to his new role and will focus on continuing to bring value and growth opportunities to all the company’s partners,” said McKesson Corp.’s Executive Vice President and Group President Paul Julian in a press release.
“I am delighted to take on this new role and continue the work initiated with Nick Loporcaro to position McKesson Canada for future growth,” said Champagne in a press release. “Our portfolio of businesses allows us to solve the significant health care challenges we face as a country. We are committed to bringing added-value serices and solutions to all our customers and partners with the ultimate goal of improving patient access to care and outcomes.”
